throbber
J. Am. Chem. Soc. 1996, 118, 557-579
`
`557
`
`Stereocontrolled Total Synthesis of (+)-Paraherquamide B^
`Timothy D. Cushing,‡ Juan F. Sanz-Cervera,† and Robert M. Williams*
`Contribution from the Department of Chemistry, Colorado State UniVersity,
`Fort Collins, Colorado 80523
`ReceiVed August 7, 1995X
`
`Abstract: The convergent stereocontrolled, asymmetric total synthesis of (+)-paraherquamide B is described. Key
`features of this synthesis include (1) an improved procedure to effect reduction of unprotected oxindoles to indoles;
`(2) a complex application of the Somei/Kametani coupling reaction; (3) a high-yielding and entirely stereocontrolled
`intramolecular SN2¢ cyclization reaction that constructs the core bicyclo[2.2.2] ring system; (4) a mild Pd(II)-mediated
`cyclization reaction that constructs a complex tetrahydrocarbazole; and (5) the chemoselective reduction of a highly
`hindered tertiary lactam in the presence of an unhindered secondary lactam, utilizing precoordination of the more
`reactive secondary lactam to triethylaluminum.
`
`Introduction
`
`The paraherquamides are complex, heptacyclic, toxic mold
`metabolites with potent anthelmintic activity isolated from
`various Penicillium sp. The parent and most potent derivative,
`paraherquamide A (1), was first isolated from Penicillium
`parherquei in 1980 by Yamazaki.1 The simplest member,
`paraherquamide B (2), plus five other structurally related
`paraherquamides C-G (3-9) were isolated from Penicillium
`charlesii (fellutanum) (ATCC 20841) in 1990 at Merck & Co.2,3
`and concomitantly at SmithKline Beecham.4 More recently
`three additional related compounds were discovered by the same
`group at SmithKline.5 Interest in the paraherquamides has come
`from the finding that this class of alkaloids displays potent
`anthelmintic and antinematodal properties.6,7
`There are essentially three classes of broad-spectrum anthel-
`mintics currently in use:
`the benzimidazoles, the levamisoles/
`morantels, and the avermectins/milbemycins. Unfortunately, the
`first two groups have lost much of their utility due to the recent
`appearance of drug resistance built up by the helminths.7a,8 More
`^ Dedicated to Professor Ei-ichi Negishi on the occasion of his 60th
`birthday.
`† On leave from the Department of Organic Chemistry of the University
`of Valencia, Spain.
`‡ Present address: Tularik Inc., 270 East Grand Ave., South San
`Francisco, CA 94080.
`X Abstract published in AdVance ACS Abstracts, December 1, 1995.
`(1) (a) Yamazaki, M.; Fujimoto, H.; Okuyama, E.; Ohta, Y. Proc. Jpn.
`Assoc. Mycotoxicol. 1980, 10, 27. (b) Yamazaki, M.; Okuyama, E.;
`Kobayashi, M.; Inoue, H. Tetrahedron Lett. 1981, 22, 135.
`(2) (a) Blizzard, T. A.; Marino, G.; Mrozik, H.; Fisher, M. H.; Hoogsteen,
`K.; Springer, J. P. J. Org. Chem. 1989, 54, 2657. (b) Blizzard, T. A.; Mrozik,
`H.; Fisher, M. H.; Schaeffer, J. M. J. Org. Chem. 1990, 55, 2256. (c)
`Blizzard, T. A.; Margiatto, G.; Mrozik, H.; Schaeffer, J. M.; Fisher, M. H.
`Tetrahedron Lett. 1991, 32, 2437. (d) Blizzard, T. A.; Margiatto, G.; Mrozik,
`H.; Schaeffer, J. M.; Fisher, M. H. Tetrahedron Lett. 1991, 32, 2441. (e)
`Blizzard, T. A.; Rosegay, A.; Mrozik, H.; Fisher, M. H. J. Labelled Compd.
`Radiopharm. 1990, 28, 461.
`(3) (a) Ondeyka, J. D.; Goegelman, R. T.; Schaeffer, J. M.; Kelemen, L.
`J. Antibiot. 1990, 43, 1375. (b) Liesch, J. M.; Wichman, C. F. J. Antibiot.
`1990, 43, 1380.
`(4) Blanchflower, S. E.; Banks, R. M.; Everett, J. R.; Manger, B. R.;
`Reading, C. J. Antibiot. 1991, 44, 492.
`(5) Blanchflower, S. E.; Banks, R. M.; Everett, J. R.; Reading, C. J.
`Antibiot. 1993, 46, 1355.
`(6) Ostlind, D. A.; Mickle, W. G.; Ewanciw, D. V.; Andriuli, F. J.;
`Campbell, W. C.; Hernandez, S.; Mochaeles, S.; Munguira, E. Res. Vet.
`Sci. 1990, 48, 260.
`(7) (a) Shoop, W. L.; Egerton, J. R.; Eary, C. H.; Suhayda, D. J. Parasitol.
`1990, 76 (2) 186. (b) Shoop, W. L.; Michael, B. F.; Haines, H. W.; Eary,
`C. H. Vet. Parasitol. 1992, 43, 259. (c) Schaeffer, J. M.; Blizzard, T. A.;
`Ondeyka, J.; Goegelman, R.; Sinclair, P. J.; Mrozik, H. Biochem. Pharmacol.
`1992, 43, 679. (d) Shoop, W. L.; Haines, H. W.; Eary, C. H.; Michael, B.
`F. Am. J. Vet. Res. 1992, 53, 2032.
`
`recently drug resistance to the avermectins has been observed
`in various parasites.9 The paraherquamides represent an entirely
`new structural class of antiparasitic agents, which promise to
`play a significant role in the near future. The relatively low
`culture yields of paraherquamide obtained for biological study
`have slowed the development and potential commercialization
`of these agents (Figure 1).
`As part of our ongoing efforts to elucidate the biosynthesis
`of the core bicyclo[2.2.2] ring system of the related alkaloids
`the brevianamides,10 we have applied methodology originally
`developed for the stereocontrolled total synthesis of (-)-
`brevianamide B11 to complete the first stereocontrolled total
`synthesis of (+)-paraherquamide B (12);12 the results of this
`study are described in full herein.
`The paraherquamides are structurally very similar to brevi-
`anamides A and B (17 and 16)13 and marcfortines A-C (13-
`15)14 with respect to the common core bicyclo[2.2.2] ring system
`that is derived from the cycloaddition of an isoprene unit across
`the amino acid R-carbons. This close structural similarity might
`imply a related biogenesis, and the structural features of these
`substances shall be described briefly from this standpoint. The
`paraherquamides and brevianamides A and B (17 and 16) appear
`to be derived from the condensation of tryptophan and proline,
`while the marcfortines are formed from the condensation of
`tryptophan and pipecolic acid. The origin of the methyl group
`in the pyrrolidine ring of paraherquamides A and C-E and
`VM55595-7 could in principle come from the methylation of
`proline, but it seems more likely that this amino acid residue is
`derived from isoleucine. The very low fermentation yield of
`paraherquamide B may be a manifestation of poor incorporation
`of cyclo-L-trp-L-pro into the subsequent biosynthetic machinery
`
`(8) Coles, G. C. Pestic. Sci. 1977, 8, 536.
`(9) (a) Van Wyk, J. A.; Malan, F. S. Vet. Rec. 1988, 123, 226. (b)
`Echevarria, F. A. M.; Trindade, N. P. Vet. Rec. 1989, 124, 147.
`(10) (a) Sanz-Cervera, J. F.; Glinka, T.; Williams, R. M. J. Am. Chem.
`Soc. 1993, 115, 347. (b) Sanz-Cervera, J. F.; Glinka, T.; Williams, R. M.
`Tetrahedron 1993, 49, 8471.
`(11) (a) Williams, R. M.; Glinka, T.; Kwast, E. J. Am. Chem. Soc. 1988,
`110, 5927. (b) Williams, R. M.; Glinka, T.; Kwast, E.; Coffman, H.; Stille,
`J. K. J. Am. Chem. Soc. 1990, 112, 808. (c) Williams, R. M.; Glinka, T.;
`Kwast, E. Tetrahedron Lett. 1989, 30, 5575.
`(12) A preliminary account of this work has appeared: Cushing, T. D.;
`Sanz-Cervera, J. F.; Williams, R. M. J. Am. Chem. Soc. 1993, 115, 9323.
`(13) (a) Birch, A. J.; Wright, J. J. J. Chem. Soc., Chem. Commun. 1969,
`644. (b) Birch, A. J.; Wright, J. J.; Tetrahedron 1970, 26, 2339. (c) Birch,
`A. J.; Russell, R. A. Tetrahedron 1972, 28, 2999. (d) Baldas J.; Birch, A.
`J.; Russell, R. A. J. Chem. Soc., Perkin Trans. 1 1974, 50.
`(14) (a) Polonsky, J.; Merrien, M. A.; Prange, T; Pascard, C. J. Chem
`Soc., Chem Commun. 1980, 601. (b) Prange, T.; Billion, M.-A.; Vuilhorgne,
`M.; Pascard, C.; Polonsky, J. Tetrahedron Lett. 1981, 22, 1977.
`
`0002-7863/96/1518-0557$12.00/0 © 1996 American Chemical Society
`
`
` P. 1
`
`UT Ex. 2027
`SteadyMed v. United Therapeutics
`IPR2016-00006
`
`

`
`558 J. Am. Chem. Soc., Vol. 118, No. 3, 1996
`
`Cushing et al.
`
`Figure 1.
`
`or may be the result of inefficient demethylation of the
`isoleucine-derived amino acid precursor.
`The oxidation state of the amino acid-derived dioxopiperazine
`moiety remains unchanged in the case of the brevianamides,
`but for the paraherquamides and the marcfortines the tertiary
`amide residue is enzymatically reduced to a monooxopiperazine,
`a process that is known.15 The tryptophan-derived indolyl side
`chain of the paraherquamides and marcfortines is oxidized to
`spiro-oxindoles while the indolyl side chain of the brevianamides
`oxidize to spiro-indoxyls. The paraherquamides, marcfortines,
`and brevianamides all incorporate one isoprene unit that forms
`the bridging bicyclo[2.2.2] ring structure. The paraherquamides
`and marcfortines differ from the brevianamides in that a second
`isoprene unit coupled with an oxidized form of tryptophan gives
`the dioxepin (or pyran) moiety. This is one of the most
`interesting and unique features of these compounds. The gem-
`dimethyl dioxepin ring found in paraherquamides A-E (1-5)
`and marcfortines A and B (13 and 14) is a unique ring system
`among natural products. A similar structural feature was
`discovered in the antifungal natural product strobilurin G (18),16
`but this dioxepin moiety lacks the double bond found in the
`other metabolites (Figure 1).
`As outlined in Scheme 1, a convergent synthesis of the
`enantiomer of paraherquamide B (12)17 was envisioned to
`contain four key carbon-carbon bond-forming reactions. The
`
`(15) Bond, R. F.; Boeyens, J. C. A.; Holzapfel, C. V.; Steyn, P. S. J.
`Chem. Soc., Perkin Trans. 1 1979, 1751.
`(16) Fredenhagen, A.; Hug, P.; Peter, H. H. J. Antibiot. 1990, 48, 661.
`(17) The enantiomer of the natural product was selected as the target
`due to the large relative cost difference between (S)- and (R)-proline.
`
`first task would involve the construction of a suitably R-alkylated
`proline derivative.11 The second important coupling would be
`the Somei/Kametani-type alkylation18 of a suitably protected
`(20)
`gramine derivative
`and the
`requisite piperazine-
`dione (19). The third and perhaps most crucial C-C bond-
`forming reaction, providing the core bicyclo[2.2.2] ring system,
`was a stereofacially controlled intramolecular SN2¢ cyclization
`reaction that sets the stereochemistry at C-20 (paraherquamide
`numbering) and concomitantly installs the isopropenyl group
`that will be utilized in the fourth C-C bond-forming reaction.
`This isopropenyl group, in turn, would be conscripted for an
`olefin-cation cyclization to provide the heptacyclic tetrahy-
`drocarbazole. Standard procedures to effect this transformation
`involve strong protic acids,11,19 and there was reason for concern
`about the reactivity of the more highly oxygenated indole (22)
`as a practical synthetic precursor to 23. The penultimate step,
`a regio- and stereofacially controlled oxidative spirocyclization
`reaction, must be accomplished to construct the desired spiro-
`oxindole. A number of these transformations were explored
`during the course of the investigations on the synthesis of (-)-
`brevianamide B,11 including a simple oxindole model study,11c
`which set a firm foundation for addressing some of the
`
`(18) (a) Somei, M.; Karasawa, Y.; Kaneko, C. Heterocycles 1981, 16,
`941. (b) Kametani, T.; Kanaya, N.; Ihara, M. J. Am. Chem. Soc. 1980, 102,
`3974.
`(19) (a) Stoermer, D.; Heathcock, C. H. J. Org. Chem. 1993, 58, 564.
`(b) Guller, R.; Dobler, M.; Borschberg, H.-J. HelV. Chim. Acta 1991, 74,
`1636. (c) Darbre, T.; Nussbaumer, C.; Borschberg, H.-J. HelV. Chim. Acta
`1984, 67, 1040. (d) Delpech, B.; Khuong-Huu, Q. J. Org. Chem. 1978, 43,
`4898.
`
`
` P. 2
`
`UT Ex. 2027
`SteadyMed v. United Therapeutics
`IPR2016-00006
`
`

`
`Stereocontrolled Total Synthesis of (+)-Paraherquamide B
`
`J. Am. Chem. Soc., Vol. 118, No. 3, 1996 559
`
`Scheme 1
`
`Scheme 2
`
`stereochemical and regiochemical issues that would be faced
`in attacking the paraherquamide ring system.
`
`Results and Discussion
`Construction of the Dioxepinooxindole Ring System. The
`prenylated catechol ring system of the paraherquamides is an
`unusual oxidative cyclization product that previously has not
`been observed to occur in metabolites of mixed biogenetic
`origin. Although the parent 2H-1,5-benzodioxepin has been
`synthesized previously,20 to the best of our knowledge there
`has been no reported synthesis of the corresponding isoprenyl
`dioxepin ring system of paraherquamide. The synthesis of this
`ring system was explored in a simple model study employing
`prenylated catechol 24 (Scheme 2).21
`It was speculated that
`the requisite 7-endo-tet cyclization reaction would be facilitated
`by a stabilized tertiary carbocation provided by the prenyl
`substituent.
`The first attempt at effecting this cyclization reaction
`
`(20) Guillaumet, G.; Coudert, G.; Loubinnoux, B. Angew. Chem., Int.
`Ed. Engl. 1983, 22, 64.
`
`(21) Williams, R. M.; Cushing, T. D. Tetrahedron Lett. 1990, 31, 6325.
`
`employed a phenylselenoetherification.22 Following a procedure
`of Clive,23 24 cyclized to 25 with either PhSeCl or N-
`phenylselenophthalimide (N-PSP),24 although in very low yield.
`The main byproducts came from the electrophilic addition across
`the double bond, electrophilic aromatic substitution of the phenyl
`ring by the phenyl selenide, and phenolic attack at the methylene
`producing the six-membered-ring product. The selenide 25 was
`treated with H2O2 and the resulting selenoxide thermally
`eliminated providing the unique dioxepin 26 in 49% yield.
`Due to the low yield of the phenylselenoetherification, an
`alternative procedure involving epoxidation followed by a Lewis
`acid-mediated ring closure was investigated.25 The prenylated
`catechol 24 was epoxidized with buffered m-CPBA to provide
`epoxide 27, which was treated with stannic chloride to give the
`dioxepin 28. A major side product in this reaction was a ketone,
`
`(22) (a) Nicolaou, K. C. Tetrahedron 1981, 37, 4097. (b) Nicolaou, K.
`C.; Magolda, R. L.; Sipio, W. J.; Barnette, W. E.; Lysenko, Z.; Joullie, M.
`M. J. Am. Chem. Soc. 1980, 102, 3784. (c) Clive, D. L. J. Tetrahedron
`1978, 34, 1049-1132.
`(23) (a) Clive, D. J. L.; Chiiattu, G.; Curtis, N. J.; Kiel, W. A.; Wong,
`C. K. J. Chem. Soc., Chem. Commun. 1977, 725. See also: (b) Liotta, D.;
`Zima, G. Tetrahedron Lett. 1978, 50, 4977. (c) Tiecco, M.; Testaferri, L.;
`Tingoli, M.; Bartoli, D.; Balducci, R. J. Org. Chem. 1990, 55, 429.
`(24) Nicolaou, K. C.; Claremon, D. A.; Barnette, W. E.; Seitz, S. P. J.
`Am. Chem. Soc. 1979, 101, 3704.
`(25) (a) Cookson, R. C.; Liverton, N. J. J. Chem. Soc., Perkin Trans. 1
`1985, 1589. (b) Kocienski, P.; Love, C.; Whitby, R.; Roberts, D. A.
`Tetrahedron Lett. 1988, 29, 2867. See also: (c) Nicolaou, K. C.; Prasad,
`C. V. C.; Somers, P. K.; Hwang, C.-K. J. Am. Chem. Soc. 1989, 111, 5335.
`
`
` P. 3
`
`UT Ex. 2027
`SteadyMed v. United Therapeutics
`IPR2016-00006
`
`

`
`560 J. Am. Chem. Soc., Vol. 118, No. 3, 1996
`
`Cushing et al.
`
`Scheme 3a
`
`a Reagents and conditions: (a) 4.0 equiv of NaOH, 1.0 equiv of 30% H2O2, 81-93%; (b) H2, Pd/C, AcOH, 92%; (c) 2.5 equiv of BBr3, CH2Cl2,
`-78 (cid:176)C, 99%; (d) 1.2 equiv of prenyl bromide, 1.1 equiv of K 2CO3, DMF, 0 (cid:176)C to room temperature, 52%; (e) m-CPBA, NaHCO3, CH2Cl2; (f) 1.2
`equiv of SnCl4, THF, 64%; (g) 1.6 equiv of NaBH4, 3.5 equiv of BF3(cid:226)OEt2, THF, 44-50%; (h) t-BuMe2SiCl, im, DMF, 40 (cid:176)C, 83%; (i) CH 2O,
`HNMe2, AcOH, H2O, 99%.
`
`resulting from a 1,2 hydride shift.26 A number of methods were
`explored to effect the dehydration of the secondary alcohol of
`dioxepin 28; the best result was realized with methyltriphenoxy-
`phosphonium iodide (MTPI) in HMPA to provide 26.27
`With a proven method accessible for the construction of the
`dioxepin ring system, attention was focused on constructing the
`requisite gramine derivative. Oxygenated indoles are notori-
`ously unstable and undergo facile autoxidation,28 photooxida-
`tion,29 dimerization, and polymerization.30
`In light of this
`problematic reactivity, our plan called for formation of the
`dioxepin ring system prior to indole (gramine) formation. The
`approach employed involved the formation of a suitably
`substituted oxindole (essentially a protected indole), followed
`by the construction of the dioxepin and final elaboration into
`the gramine derivative.
`The known pyruvic acid 29 (Scheme 3)31 (prepared in five
`steps from vanillin) was oxidatively decarboxylated32 to afford
`the phenylacetic acid 30, which was reductively cyclized to give
`the required oxindole 3133 in nearly quantitative yield.
`At this point, a method was needed to differentiate between
`the two phenolic substituents for the prenylation reaction. A
`number of attempted selective protecting group strategies were
`
`(26) For a related observation, see: Taylor, S. T.; Davisson, M. E.;
`Hissom, B. R., Jr.; Brown, S. J.; Pristach, H. A.; Schramm, S. B.; Harvey,
`S. M. J. Org. Chem. 1987, 52, 425.
`(27) Hutchins, R. O.; Hutchins, M. G.; Milewski, C. A. J. Org. Chem.
`1972, 37, 4191.
`(28) Houlihan, W. J.; Remers, W. A.; Brown, R. K. Indoles, Part one,
`The Chemistry of Heterocycles; John Wiley & Sons, Inc.: New York, 1972.
`(29) (a) Chan, A. C.; Hilliard, P. R., Jr. Tetrahedron Lett. 1989, 30, 6483.
`(b) d’Ischia, M.; Prota, G. Tetrahedron 1987, 43, 431.
`(30) This difficulty was observed in a short synthesis of the known
`6-acetoxy-7-methoxyindole (i). The unstable substance i was treated with
`TMSI, producing the dimer ii as the sole product.
`
`See: (a) Walker, G. N. J. Am. Chem. Soc. 1955, 77, 3844. (b) Burton, H.;
`Duffield, J. A.; Prail, P. F. G. J. Chem. Soc. 1950, 1062. (c) Beer, R. J. S.;
`Mcgrath, L.; Robertson, A.; Woodier, A. B. J. Chem. Soc. 1949, 2061. (d)
`Beer, R. J S.; Clarke, K.; Khorana, H. G.; Robertson, A. J. Chem. Soc.
`1948, 2223. (e) Chan, A. C.; Hilliard, P. R., Jr. Tetrahedron Lett. 1989, 30,
`6483. (f) d’Ischia, M.; Prota, G. Tetrahedron 1987, 43, 431. (g) Deibel, R.
`M. B.; Chedekel, M. R. J. Am. Chem. Soc. 1984, 106, 5884. (h) Heacock,
`R. A. Chem. ReV. 1959, 59, 181.
`(31) (a) Beer, R. J. S.; Clarke, K.; Davenport, H. F.; Robertson, A. J.
`Chem. Soc. 1951, 2029. (b) Bennington, F.; Morin, R. D.; Clark, L. C., Jr.
`J. Org. Chem. 1959, 24, 917.
`(32) Kosuge, T.; Ishida, H.; Inabe, A.; Nukaya, H. Chem. Pharm. Bull.
`1985, 33, 1414.
`
`explored, but nothing satisfactory was found; it was thus decided
`to forgo any protecting group for the 6-hydroxy position.
`Oxindole 31 was cleanly demethylated upon treatment with
`(clear) boron tribromide. The resulting oxindole 32 was
`subjected to the prenylation conditions, and the desired alkylated
`product 33 was obtained in 52% yield.34,35 Both of the methods
`discussed above for the formation of the seven-membered ring
`were examined. The phenylselenoetherification procedure failed
`on this substrate, and only products resulting from electrophilic
`aromatic substitution were formed.
`The alternative epoxidation/Lewis acid-mediated cyclization
`again proved to be successful on this substrate. The epoxidation
`reaction (m-CPBA) had to be buffered with NaHCO3, to prevent
`the formation of the six-membered-ring tertiary alcohol. In most
`cases, the reaction was worked up and taken on to the next
`step without purification (the labile epoxide tended to cyclize
`to the six-membered tertiary alcohol upon contact with silica
`gel). The incipient epoxide product was directly treated with
`SnCl4 in THF to provide the desired seven-membered-ring
`alcohol 34 (64% overall yield from 33).
`N-Alkylated oxindoles have been reported to be reduced to
`indoles by the use of DIBAL or LiAlH4;36 however, in the case
`of unsubstituted oxindoles, this reduction either fails or requires
`
`(33) This material has interesting chemical and physical characteristics.
`The solvent must be removed immediately after the hydrogenolysis to
`prevent the white product from turning to a black sludge. This oxindole 31
`would also change from a white color to a metallic gray simply by drying
`on the vacuum pump. These decomposition properties are no doubt due to
`the autoxidation of the indole tautomer form.
`(34) The undesired regioisomer was obtained in less than 1% yield, and
`the bis-alkylated material was produced in only 8.3% yield. This selectivity
`is presumably a manifestation of the domination of inductive effects of the
`amide functionality directing the alkylation to the 7-position.
`(35) The structure of compound 33 was confirmed by simply tosylating
`33 and comparing the product (37) to the same substance prepared from
`31. The two independently synthesized products were identical in every
`way.
`
`(36) (a) Kishi, Y.; Nakatsuka, S.; Fukuyama, T.; Havel, M. J. Am. Chem.
`Soc. 1973, 95, 6494. (b) Robinson, B. Chem. ReV. 1969, 69, 785.
`
`
` P. 4
`
`UT Ex. 2027
`SteadyMed v. United Therapeutics
`IPR2016-00006
`
`

`
`Stereocontrolled Total Synthesis of (+)-Paraherquamide B
`
`J. Am. Chem. Soc., Vol. 118, No. 3, 1996 561
`
`Scheme 4a
`
`a Reagents and conditions: (a) 36, 0.5 equiv of PBu3, MeCN, 51%; (b) DMAP, Et3N, BOC2O, CH2Cl2, 90%; (c) 5 equiv of LiCl, 1.5 equiv of
`H2O, HMPA, 100 (cid:176)C, 66%; (d) 3.0 equiv of n-Bu4NF, THF, 79%; (e) 1.9 equiv of LiCl, 4.0 equiv of collidine, 4.0 equiv of MsCl, DMF, 86%; (f)
`t-BuMe2SiOTf, 2,6-lutidine,CH2Cl2, 76%; (g) 10 equiv of NaH, benzene, 11%.
`
`Figure 2.
`
`In 1972 it was reported37 that
`more vigorous conditions.
`substituted and unsubstituted oxindoles could be reduced to the
`corresponding indole in high yields with borane in THF at 0
`(cid:176) C. Oxindole 34 was subjected to these conditions (1.0 M BH3/
`THF, Aldrich), but with no reaction. However, when oxindole
`34 was treated with 1.6 equiv of NaBH4 and 3.5 equiv of BF3(cid:226)-
`OEt2 in THF for 1 day (0 (cid:176)C to room temperature), the desired
`indole 35 was obtained in 43-50% yield. The indole 35 was
`treated with a warm solution of TBDMSCl and imidazole in
`DMF, to provide the required O-silylated indole, which was
`easily converted to the gramine 36 through the well-known
`Mannich procedure (Scheme 3).
`Construction of the Bicyclo[2.2.2] Ring System. To probe
`the stability of the dioxepin-indole in subsequent transforma-
`tions, a model study involving the previously synthesized
`racemic piperazinedione 3838 was investigated (Scheme 4).
`Indole 36 was condensed with the piperazinedione 38 following
`the Somei/Kametani conditions18 to give the desired syn product
`39 (a racemic mixture of two diastereomers) in 51% yield. The
`relative stereochemistry of this substance was evident by an
`examination of the 1H NMR spectrum. There is a large upfield
`shift of the proline ring protons of 39 ((cid:228) Ha, Hb, Hc; 0.03-
`0.19 (m), 0.43-0.52 (m), 0.62-0.72 (m) ppm).
`It is well-
`known that N-alkylated piperazinediones prefer to adopt a boat-
`like conformation due to the planar geometry of the amides and
`A-1,3 steric interactions of N-alkyl residues. This forces the
`
`substituents on the amino acid R-carbons to adopt either
`pseudoaxial or pseudoequatorial dispositions. In conformer B
`(Figure 2) the carbomethoxy group is sterically congested by
`the bulky isopentenyl group,
`favoring the alternate boat
`conformer (A), which positions the indole ring under the
`piperazinedione, positioning the two pyrrolidine protons Ha and
`Hb directly over the shielding cone of the aromatic indole ring
`system; the corresponding anti-isomer cannot adopt this type
`of conformation. Furthermore, a consideration of the mecha-
`nism of the Somei/Kametani reaction18 supports the expectation
`that the syn-isomer (39) should be the major product. The
`gramine derivative (36) reacts with tributylphosphine to form
`a bulky (tributylphosphino)indole intermediate that can only
`approach from the less congested face of the piperazinedione
`enolate, away from the isopentenyl moiety.
`A similar phenomenon was observed when 39 was subjected
`to the decarbomethoxylation procedure (LiCl, H2O, HMPA)
`directly. The two main products isolated were the syn-isomer
`40 and the anti-isomer 41, in a ratio of 3.3:1.0 (Figure 3). These
`stereochemical assignments were made by comparing the 1H
`NMR spectral data of 40 and 41. There was a pronounced
`upfield shift of three pyrrolidine ring protons in compound 41,
`a shift that is not observed for diastereomer 40.
`Piperazinedione 39 was first converted to the BOC-protected
`indole 42, which was subsequently subjected to a decar-
`bomethoxylation reaction supplying the syn-diastereomer 43 as
`
`(37) Sirowej, H.; Khan, S. A.; Plieninger, H. Synthesis 1972, 84.
`
`(38) Williams, R. M.; Glinka, T. Tetrahedron Lett. 1986, 27, 3581.
`
`
` P. 5
`
`UT Ex. 2027
`SteadyMed v. United Therapeutics
`IPR2016-00006
`
`

`
`562 J. Am. Chem. Soc., Vol. 118, No. 3, 1996
`
`Cushing et al.
`
`Figure 3.
`
`Scheme 5a
`
`a Reagents and conditions: (a) 3.8 equiv of CAN (0.33 M), 2:1 CH3CN/H2O, 2 h, 79%; (b) (i) 2 equiv of NaBH4, EtOH; (ii) t-BuPh2SiCl, im,
`DMF, 75%; (c) (i) 1.0 equiv of n-BuLi, 1.1 equiv of MeOCOCl, -78 (cid:176)C; (ii) 2.2 equiv of LiN(SiMe 3)2, 1.1 equiv of MeOCOCl, THF, -100 (cid:176)C,
`93%; (d) 36, 0.5 equiv of PBu3, CH3CN, reflux, 73%; (e) LiCl, HMPA, 100 (cid:176)C ( syn/anti 3:1), 89%; (f) Me3OBF4, Na2CO3, CH2Cl2 (syn, 81%; anti,
`62-71%); (g) (i) BOC2O, DMAP, Et3N, CH2Cl2; (ii) n-Bu4NF, THF (syn, 90%; anti, 85%); (h) NCS, Me2S (syn, 74-81%; anti, 86%).
`
`the major product. Compound 43 (the minor, anti-diastereomer
`was not utilized) was desilylated to provide the diol 44, which
`was converted to the allylic chloride 45. Careful treatment of
`45 with t-BuMe2SiOTf, to prevent transesterification of the BOC
`groups,39 gave the desired product 46 in 76% yield. Allylic
`chloride 46 was subjected to 10 equiv of NaH in refluxing
`benzene, but the reaction proved extremely sluggish. After 5
`days, the desired product 47 was obtained in a poor 11% yield
`(19% based on recovered 46; accompanied by extensive
`decomposition). The syn-isomer 47 was the only stereoisomer
`formed in this reaction; the corresponding anti-isomer was not
`detected. While this reaction demonstrated the potential viability
`of the stereoselective intramolecular SN2¢ reaction, work on the
`racemic model system was halted, due to the low yield in this
`
`(39) Sakaitani, M.; Ohfune, Y. J. Am. Chem. Soc. 1990, 112, 1150.
`
`key transformation coupled with perceived difficulties associated
`with removing the N-p-methoxybenzyl group.
`Total Synthesis of (+)-Paraherquamide B. Starting from
`the known piperazinedione 48 (prepared in eight steps from (S)-
`proline),11 the enal 49 was obtained in 79% yield by treatment
`of 48 with a 0.33 M solution of ceric ammonium nitrate (Scheme
`5).40 The resulting product (49) was reduced with NaBH4 and
`protected with t-BuPh2SiCl in a two-step process to give the
`silyl ether 50 in 75% yield. Compound 50 was then subjected
`to a two-step, one-pot acylation providing the required substrate
`51 in 93% yield. The crude material was a mixture of epimers
`in a ratio of approximately 4:1 (syn:anti).
`Interestingly this
`mixture had a tendency to epimerize during column chroma-
`
`(40) Yoshimura, J.; Yamaura, M.; Suzuki, T.; Hashimoto, H. Chem. Lett.
`1983, 1001.
`
`
` P. 6
`
`UT Ex. 2027
`SteadyMed v. United Therapeutics
`IPR2016-00006
`
`

`
`Stereocontrolled Total Synthesis of (+)-Paraherquamide B
`
`J. Am. Chem. Soc., Vol. 118, No. 3, 1996 563
`
`Figure 4.
`
`Scheme 6
`
`tography, resulting in an increase in the proportion of the syn-
`isomer. The two products were combined and condensed with
`the gramine 36 providing the indole 52 in 73% yield as a mixture
`of two diastereomers (epimeric at
`the secondary alcohol
`stereogenic center). Interestingly, the imidic carbamate group
`was also cleaved in the course of this reaction. Compound 52
`was subjected to the decarbomethoxylation procedure, affording
`a 3:1 mixture of 53 (syn) and 54 (anti) in 89% combined yield.
`The lactam 53 could be converted to the N-BOC-protected
`allylic chloride 55 in four steps and in good overall yield
`(Scheme 6), but numerous attempts to effect the SN2¢ reaction
`on this substrate failed. These reactions were capricious and
`were accompanied by the occasional appearance of the spiro-
`lactones 56 and 57, formed in low yield <5% (Figure 4).
`It
`seems likely that the failure of 55 to cyclize in the desired
`fashion can be attributed to nonbonding interactions between
`the tert-butoxycarbonyl group and the pendant dioxepin in-
`dole.41,42
`These observations dictated that a suitable amide protecting
`group would have to be selected that was less electron
`withdrawing and less sterically demanding than both the tert-
`butoxycarbonyl and the p-methoxybenzyl groups. The loss of
`the lactam methoxycarbonyl group in the alkylation of 51 with
`the gramine 36 was presumably due to N f N acyl transfer to
`dimethylamine, a byproduct of the Somei/Kametani reaction.
`This appears to be a general reaction that was used to selectively
`deprotect the N-tert-butoxycarbonyl group of 58 without de-
`blocking the N-tert-BOC-protected indole. Thus, refluxing a
`
`(41) The formation of the two spiro compounds 56 and 57 is presumably
`due to the increased electrophilicity of the N-acylated amide. Apparently,
`trace moisture in the reaction mixture caused the production of hydroxide,
`which then hydrolyzed the reactive amide bond. The resulting carboxylic
`acid cyclized in an SN2¢ fashion, furnishing the spiro lactones.
`(42) (a) Giovannini, A.; Savoia, D.; Umani-Ronchi, A. J. Org. Chem.
`1989, 54, 228. (b) Flynn, D. L.; Zelle, R. E.; Grieco, P. A. J. Org. Chem.
`1983, 48, 2424.
`
`solution of 58 and Me2NH in CH3CN furnished compound 59
`in 92% yield43 (Scheme 7).
`The strategy planned for the reduction of the tertiary amide
`called for the protection of the secondary lactam as a lactim
`ether,44 and this group seemed suitable for use earlier in the
`synthesis and appeared compatible with the SN2¢ cyclization.
`Thus, syn-isomer 53 was treated with 20 equiv (optimum) of
`Na2CO3 and 5 equiv of Me3OBF4 in dichloromethane for 4 h,
`to yield 81% of compound 60. Even though the next two
`reactions could be carried out in a stepwise fashion, it proved
`most convenient to convert 60 directly to the protected diol 62
`in a one-pot, two-step sequence. Diol 62 was then subjected
`to the chlorination procedure successfully used in the conversion
`of diol 44 to the allylic chloride 45. Unfortunately, under these
`conditions, the reaction failed and the lactim ether was cleanly
`deblocked back to the lactam. This problem was finally solved
`by following the procedure of Corey,45 which called for the
`addition of compound 62 to a mixture of N-chlorosuccinimide
`and dimethyl sulfide, which yielded the chloride 64 in 81%
`yield.
`Allylic chloride 64 was reprotected with t-BuPh2SiOTf to
`provide 66 in 77-82% yield. The stage was now set to effect
`the SN2¢ reaction. Compound 66 was refluxed in benzene with
`20 equiv of sodium hydride, resulting in a very clean and high-
`yielding cyclization reaction furnishing the desired product 68
`in 93% yield (Scheme 8).
`(43) This result is noteworthy, especially in light of a report that tert-
`butoxycarbonyl-protected amides are cleaved to the tert-butoxycarbonyl-
`protected amines with DEAEA (2-(N,N-diethylamino)ethylamine) in CH3CN
`at room temperature; see: Grehn, L.; Gummarsonn, K.; Ragnarsson, U.
`Acta Chem. Scand. B 1987, 41, 18. However, the substrates examined in
`that report were all open-chain amides. Interestingly it is known that BOC-
`protected lactams can be cleaved by base but it is the amide bond that is
`broken as was observed on substrate 55. Recently it has been reported that
`Mg(OMe)2 will also cleave lactam carbamates including BOC-protected
`lactams; see: Wei, Z.-Y.; Knaus, E. E.; Tetrahedron Lett. 1994, 35, 847.
`(44) Williams, R. M.; Brunner, E. J.; Sabol, M. R. Synthesis 1988, 963.
`(45) Corey, E. J.; Kim, C. U.; Takeda, M. Tetrahedron Lett. 1972, 13,
`4339.
`
`
` P. 7
`
`UT Ex. 2027
`SteadyMed v. United Therapeutics
`IPR2016-00006
`
`

`
`564 J. Am. Chem. Soc., Vol. 118, No. 3, 1996
`
`Cushing et al.
`
`Scheme 7
`
`Scheme 8
`
`This last series of reactions was also carried out in parallel
`on the anti-isomer 54. Following the same sequence (five steps)
`we obtained the fully protected chloride 67 in good yield. The
`chloride 67 was then refluxed in benzene with the required
`amount of sodium hydride to yield the same product (68, 85%
`
`yield) as that obtained from 66. The yields of 68 from both
`routes were very high, and the undesired anti-diastereomer was
`not detected. The high degree of facial selectivity observed in
`the cyclizations to 68 and 47 is quite interesting and warrants
`It is generally accepted that SN2¢ reactions
`some comments.
`
`
` P. 8
`
`UT Ex. 2027
`SteadyMed v. United Therapeutics
`IPR2016-00006
`
`

`
`Stereocontrolled Total Synthesis of (+)-Paraherquamide B
`
`J. Am. Chem. Soc.

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket